Compare DexCom, Inc. (DXCM) vs Shopify Inc. (SHOP) Price & Performance

DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.

The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.

Shopify (SHOP) trades at $125.86, up 0.14% on the day, with a bullish technical signal from moving averages and support at $121. The company reported $11.56B revenue in 2025 with a 10.77% net margin, though valuation ratios remain elevated with a P/E of 121. Recent analyst upgrades highlight AI commerce growth potential.

Outlook is positive with a $150.08 consensus price target and 67% buy ratings, but high valuation and competitive pressures pose risks. Earnings beat in Q1 2026 supports momentum, yet investors should weigh growth against premium multiples in a volatile market.